Back to results

University of Illinois at Urbana-Champaign

Adapting a gelatin hydrogel platform to investigate glioblastoma progression

Abstract

dc:description

According to the World of Health Organization, cancer is the leading cause of death worldwide, responsible for approximately 1 in 6 deaths globally. In the United States alone, there are approximately 80,000 new cases of primary brain tumors diagnosed annually, with a third of those being malignant brain cancer. Glioblastoma is the most common and lethal form of adult brain cancer, contribute to about 13,000 new cases annually in the U.S. Despite current clinical standard-of-care, which involves surgical tumor debulking followed by chemotherapy and radiotherapy, patient prognosis remains poor (median survival ~15 months; 5+ year survival <5-15%) and has not significantly improved for decades. Poor survival is linked to the rapid, diffuse infiltration of GBM throughout the brain and the inability to surgically resect or therapeutically target these diffusely spread cells. While significant insight has been gained to how structural or mechanical features of the tumor microenvironment may influence GBM invasion, it is unclear how cohorts of diverse cells that exist within the tumor microenvironment shape GBM invasion and drug resistance. This dissertation describes a bioengineering approach to develop biomaterial models of the GBM tumor microenvironment to study how structural (stiffness, hyaluronan content) and metabolic (e.g., hypoxia) gradients within the tumor margin, as well as the heterogenous cellular make-up of the GBM tumor shape its progression. We fabricated brain mimetic hydrogels matching biophysical features of the tumor and margins, designed culture conditions mimicking tumor hypoxia and activation of microglia immune cells from the GBM tumor microenvironment. Together, we showed that the combined influence of transitions in biophysical and biochemical composition as well as the immune cells greatly influence on GBM invasion, bringing new insight to potential therapeutic interventions to better target this disease.

Degree

thesis:*
Name thesis:degree_name
Ph.D.
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemical Engineering
Grantor
University of Illinois at Urbana-Champaign
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chen, Jee-Wei Emily
Contributors dc:contributor
  • Harley, Brendan
  • Kraft, Mary
  • Gaskins, H Rex
  • Kong, Hyun Joon

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • Copyright 2020 Jee-Wei Chen
Language dc:language
en

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2142/108080
OAI identifier oai:identifier
oai:www.ideals.illinois.edu:2142/108080

Chain of custody

source
Harvested from
University of Illinois - Urbana-Champaign
Base URL
www.ideals.illinois.edu/oai-pmh
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Chen, Jee-Wei Emily. Adapting a gelatin hydrogel platform to investigate glioblastoma progression. Dissertation thesis, University of Illinois at Urbana-Champaign, 2020. http://hdl.handle.net/2142/108080